Bristol-Myers Squibb Company (BMY) Q4 2016 Earnings Results

Bristol Myers Squibb Misses on EPS — Stock Down 5.5%

Bristol Myers Squibb's earnings report indicates a slight miss on EPS expectations, contributing to a notable stock decline of 5.5%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. The defensive tone from management suggests they are aware of the challenges ahead and are focusing on long-term strategies.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.63	N/A	-4.26%

Management

Management commentary

Tone: Defensive

Management expressed concern over recent performance metrics. They reiterated their commitment to navigating market challenges.

Management acknowledged challenges in the current market environment.

They emphasized a focus on long-term growth despite short-term hurdles.

Bristol Myers Squibb Misses on EPS — Stock Down 5.5%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol Myers Squibb Misses on EPS — Stock Down 5.5%

Key numbers

Management commentary